- This event has passed.
SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3 (ML3)
October 26 @ 12:00 pm - 1:00 pm
The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on our recent accolade of attaining the World Health Organisation (WHO) Maturity Level 3 (ML3) for vaccine production.
We had invited some of our Executives, CEO Dr. Boitumelo Semete-Makokotlela, CRO Portia Nkambule, and COO Christelna Reynecke to unpack this global accolade by sharing insights and the impact of receiving this WHO rating.
Our conversation focused on:
- Understanding of the opportunities that come with an ML3 ranking for South Africa
- Improved understanding of the influence of ML3 on the African vaccine production industry
- The impact of ML3 on the South African economy and its citizens
Watch webinar recording below: